HIV/AIDS Topics CROI: Infants with HIV Who Receive Early ART Can Safely Stop Treatment
- Details
- Category: HIV Disease Progression
- Published on Thursday, 22 March 2012 00:00
- Written by Press Release
HIV-infected infants who start antiretroviral therapy (ART) immediately after birth can interrupt treatment after 1-2 years and still do better than babies who delayed ART initiation until they developed symptoms, researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle.
CROI: U.S. Black Women Have Higher Rates of HIV Infection and AIDS Death
- Details
- Category: HIV Disease Progression
- Published on Wednesday, 21 March 2012 00:00
- Written by Liz Highleyman
Urban black women in the U.S. are 5 times more likely to become infected with HIV than previously estimated, and are twice as likely to die of AIDS-related causes, according to 2 posters presented this month at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.
Low but Detectable Viral Load Can Lead to HIV Rebound
- Details
- Category: HIV Disease Progression
- Published on Tuesday, 24 January 2012 00:00
- Written by Liz Highleyman
People with HIV RNA levels < 50 copies/mL but detectable may still experience viral rebound while on antiretroviral therapy, and should consider switching to a more effective regimen if low-level viral load persists, according to a study described in the January 11, 2012, advance online edition of Clinical Infectious Diseases.
Are HIV Non-Progressors Really Very Slow Progressors?
- Details
- Category: HIV Disease Progression
- Published on Friday, 24 February 2012 00:00
- Written by Liz Highleyman
HIV positive people traditionally classified as long-term non-progressors or viral controllers may in fact progress slowly over time, according to research reported in the February 20, 2012, edition of the open-access journal PLoS ONE. These findings suggest that so-called non-progressors may in fact benefit from antiretroviral therapy and could provide clues to aid in development of immune-based therapies.
Cumulative Viral Load Predicts Mortality for Untreated People with HIV
- Details
- Category: HIV Disease Progression
- Published on Tuesday, 04 October 2011 00:00
- Written by Liz Highleyman
"Viremia copy-years," or cumulative HIV viral load over time, was a good predictor of deaths due to all causes among people on combination antiretroviral therapy (ART), independent of cross-sectional, or one-time, viral load measurements or CD4 T-cell counts, researchers reported in the September 2, 2011, advance online edition of Clinical Infectious Diseases.
More Articles...
- Increased Risk of Death for HIV+ People Mostly Due to Modifiable Risk Factors
- IAS 2011: HIV Treatment In Primary Infection: 48 Week Course Modestly Delays CD4 Drop
- IAS 2011: Poor CD4 Cell Recovery after Starting HIV Treatment Should Be a Cause For Concern
- IAS 2011: Anti-Herpes Drugs Reduce HIV Viral Load, Slow Disease Progression
Web Design and Development by